BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17873707)

  • 1. Perceptual disturbances associated with low-dose bupropion sustained-release treatment.
    Liu CY; Chien YS
    J Clin Psychopharmacol; 2007 Oct; 27(5):543-4. PubMed ID: 17873707
    [No Abstract]   [Full Text] [Related]  

  • 2. Bupropion-induced neck and shoulder pain.
    Sansone RA; Sansone LA
    Pharmacopsychiatry; 2009 Sep; 42(5):203-4. PubMed ID: 19724984
    [No Abstract]   [Full Text] [Related]  

  • 3. Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine.
    Chan CH; Liu HC; Huang MC
    J Clin Psychopharmacol; 2006 Dec; 26(6):677-9. PubMed ID: 17110836
    [No Abstract]   [Full Text] [Related]  

  • 4. Bupropion sustained release: side effect profile.
    Settle EC
    J Clin Psychiatry; 1998; 59 Suppl 4():32-6. PubMed ID: 9554319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion has no effect on intraocular pressure or other ophthalmologic parameters after single or repeat doses in healthy volunteers.
    Ghibellini G; Park J; Brittain CF; Iavarone L; Andorn AC; Levy N; Muir KT
    J Clin Pharmacol; 2009 Apr; 49(4):489-95. PubMed ID: 19318697
    [No Abstract]   [Full Text] [Related]  

  • 6. Bupropion sustained release: a therapeutic overview.
    Davidson JR; Connor KM
    J Clin Psychiatry; 1998; 59 Suppl 4():25-31. PubMed ID: 9554318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion extended-release for depressive disorders.
    Jefferson JW
    Expert Rev Neurother; 2008 May; 8(5):715-22. PubMed ID: 18457528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
    Jefferson JW; Pradko JF; Muir KT
    Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
    Andrade C
    J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
    [No Abstract]   [Full Text] [Related]  

  • 12. Wellbutrin versus generic bupropion.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):54-5. PubMed ID: 18617874
    [No Abstract]   [Full Text] [Related]  

  • 13. Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers.
    Zhang F; Li Y; Hu J; Zhong J; Li H
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):339-352. PubMed ID: 30520001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure Related to the Split Extended-Release Bupropion Tablets in a Young Female Patient.
    Chou HY; Chang HA; Mao WC; Tai YM; Tzeng NS
    Am J Ther; 2019; 26(6):e777-e778. PubMed ID: 31436570
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended-release bupropion induced grand mal seizures.
    Rissmiller DJ; Campo T
    J Am Osteopath Assoc; 2007 Oct; 107(10):441-2. PubMed ID: 17956996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion for weight reduction.
    Gadde KM; Xiong GL
    Expert Rev Neurother; 2007 Jan; 7(1):17-24. PubMed ID: 17187492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute psychosis after administration of bupropion hydrochloride (Zyban)].
    Neumann M; Livak V; Paul HW
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S140-1. PubMed ID: 15570532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure secondary to Bupropion extended release preparation: A report.
    Mishra DK; Sardesai U; Rastogi P; Ramghulam
    Asian J Psychiatr; 2017 Dec; 30():86-87. PubMed ID: 28841450
    [No Abstract]   [Full Text] [Related]  

  • 19. An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey.
    Granger AL; Fehnel SE; Hogue SL; Bennett L; Edin HM
    J Affect Disord; 2006 Feb; 90(2-3):217-21. PubMed ID: 16360216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension.
    Thase ME; Haight BR; Johnson MC; Hunt T; Krishen A; Fleck RJ; Modell JG
    J Clin Psychopharmacol; 2008 Jun; 28(3):302-7. PubMed ID: 18480687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.